Bausch, MSN Strike Deal Resolving Trulance Drug Patent Fight

Bausch Health Cos. and MSN Laboratories Private Ltd. settled a nearly five-year clash over patents for the constipation drug Trulance after a November bench trial.

Judge Stanley R. Chesler granted the request by Bausch, its Salix Pharmaceuticals Inc. unit, and MSN to dismiss all claims and defenses without prejudice in an order issued Monday in the US District Court for the District of New Jersey.

The parties asked for his approval in an April 3 filing, saying they had reached a confidential settlement and license agreement. The deal resolves a dispute that consolidated four patent-infringement lawsuits over MSN’s proposed generic ...